CASP8 and ovarian carcinoma: Related to this, Cisplatin and paclitaxel-resistant ovarian cancer cells treated with ixabepilone exhibit increased expression of death receptors DR4 and DR5, along with increased APO-2L/TRAIL-induced caspase 8, indicating activation via the extrinsic apoptosis pathway [60].